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	 New	Pd(II)	and	Pt(IV)	binuclear	complexes	with	two	heterocyclic	Schiff	base	ligands	of	 type
ONO	 derived	 from	 condensation	 of	 salicylaldehyde	 with	 4‐aminoantipyrine	 have	 been
synthesized	 and	 characterized	 using	 elemental	 analysis,	 IR,	 electronic	 absorption	 spectra,
magnetic	moments.	 It	has	been	found	that	the	stoichiometric	ratio	 is	metal:ligand	(2:2)	with
Pd(II)	or	Pt(IV)	 ions	forming	binuclear	complexes.	The	electrochemistry	of	the	Pt	complexes
for	 Pt(IV)/Pt(II)	 redox	 couple	 was	 investigated	 by	 cyclic	 voltammetry.	 According	 to	 molar
conductance,	 the	 complexes	 may	 be	 formulated	 as	 [Pd2(L1)2],	 [Pt2(L1)2(H2O)4]Cl2,
[Pd2(L2)2]Cl,	 and	 [Pt2(L2)2(H2O)4]Cl3.	 On	 the	 basis	 of	 the	magnetic	moments,	 square	 planar
geometry	is	suggested	 for	Pd(II)	complexes	and	octahedral	geometry	 is	suggested	for	Pt(IV)
complexes.	 The	 antibacterial	 activity	 of	 the	 ligands	 and	 complexes	 were	 assessed	 against
Gram‐positive	 bacteria	 B.	 subtilis	 and	 S.	 aureus	 and	 Gram‐negative	 bacteria	 S.	 typhi	 and
Salmonella	spp.	
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1.	Introduction	
	
Metal	 complexes	 of	 Schiff	 bases	 occupy	 a	 central	 role	 in	
coordination	chemistry	for	analytical,	physical,	and	biochemical	
purposes	[1‐10].	Heterocyclic	phenazone	and	their	derivatives	
(4‐aminoantipyrine)	 are	 known	 to	 act	 as	 bidentate	 or	
tridentate	ligands	when	coordinated	to	metal	ion	and	can	form	
mononuclear	and	binuclear	complexes	[11‐14].		
Characterization	 and	 theoretical	 treatment	 of	 palladium	
and	 platinum	 complexes	 as	 well	 as	 their	 use	 in	 medicinal	
purposes	are	reported	[15‐20].	
In	 this	 paper,	 we	 are	 reporting	 the	 synthesis	 and	
characterization	of	the	binuclear	Pd(II)	and	Pt(IV)	complexes	of	
two	 heterocyclic	 Schiff	 base	 ligands	 containing	 4‐amino	
antipyrine.	
	
2.	Experimental	
	 	
All	 the	chemicals	and	solvents	used	for	the	synthesis	were	
reagent	 grade	 and	 procured	 from	 (BDH	 chemicals	 or	 Sigma‐
Aldrich	 or	 Fluka).	 Anhydrous	 palladium(II)	 chloride	 (59%,	
Merck)	 and	 anhydrous	 platinum(IV)	 chloride	 (57.5%,	 Merck)	
were	 used	 as	 received.	 All	 solvents	 were	 dried	 and	 purified	
before	used.	
Elemental	 analyses	 were	 determined	 at	 the	 Micro‐
analytical	 Centre,	 Cairo	 University,	 Egypt.	 IR	 spectra	 were	
recorded	 on	 Perkin	 Elmer	 (Spectrum	 1000)	 FT‐IR	 spectro‐
meter	using	KBr	pellets	at	National	Research	Center.	Electronic	
absorptions	were	 recorded	 on	 a	 Shimadzu	 UV‐240	 automatic	
spectrophotometer.	Determination	of	all	metals	percentage	by	
atomic	absorption	spectrophotometry	on	AA‐680G	(Shimadzu).	
Cyclic	voltammograms	were	obtained	at	room	temperature	
using	 a	 VersaSTAT3	 potentiostat	 from	 Princeton	 Applied	
Research	 accompanied	 by	 the	 V3	 Studio	 software.	 A	 three	
electrode	 system	 was	 used	 comprising	 a	 glassy	 carbon	
electrode	 as	 the	working	 electrode,	 a	 Pt	wire	 as	 the	 auxiliary	
electrode,	and	Ag/AgCl	(aqueous,	saturated	NaCl)	electrode	as	
the	 reference	 electrode.	 Samples	 were	 prepared	 as	 2	 mmol	
solutions	 in	 DMF	 with	 0.1	 M	 (n‐Bu4N)PF6	 as	 the	 supporting	
electrolyte.	 Reported	 values	 are	 peak	 potentials	 of	 the	
irreversible	reduction	using	a	scan	rate	of	100	mV/s.	
Molar	conductance	(S.	m2/mol),	at	25	°C	of	freshly	prepared	
(0.001	mol/L)	metal	 chelates	 in	DMF	was	determined	using	a	
YSI‐32	 model	 conductometer.	 Magnetic	 measurements	 were	
done	on	solid	complexes	using	the	Gouy	method.	Melting	points	
were	 recorded	 on	 a	 Gallenkamp	 apparatus	 and	 are	
uncorrected.	
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2.1.	Preparation	of	the	Schiff	base	ligands	(L1	and	L2)		
	 	
The	 ligands	 (L1:	 4‐(2,3‐dihydroxybenzylideneamino)‐1,5‐
dimethyl‐2‐phenyl‐1H‐pyrazol‐3(2H)‐one	and	L2:	4‐(2‐hydroxy	
benzylideneamino)‐1,5‐dimethyl‐2‐phenyl‐1H‐pyrazol‐3(2H)‐
one)	 were	 prepared	 by	 condensation	 of	 4‐aminoantipyrine	
with	 salicylaldehyde	 in	 ethanol.	 This	 preparation	 was	
performed	as	cited	in	the	literature	[21].	The	general	structures	
of	 ligands	 obtained	 from	 chemical	 analysis	 and	 spectral	
methods	are	given	in	Figure	1.	
4‐(2,3‐Dihydroxybenzylideneamino)‐1,5‐dimethyl‐2‐phenyl‐
1H‐pyrazol‐3(2H)‐one	(L1):	Yield:	84%.	M.p.:	138	°C.	IR	(KBr,	ν,	
cm‐1):	 1690	 (C=O),	 1625	 (C=N),	 1270	 (C‐O).	 UV/Vis	 (DMSO,	
λmax,	cm‐1):	26316,	28754.	34816.	Anal.	calcd.	for	C18H17N3O3:	C,	
66.86;	H,	5.30;	N,	13.00;	O,	14.84.	Found:	C,	67.28;	H,	5.27;	N,	
12.65;	O,	14.98%.	
4‐(2‐Hydroxy‐benzylideneamino)‐1,5‐dimethyl‐2‐phenyl‐1H‐
pyrazol‐3(2H)‐one	 (L2):	 Yield:	 88%.	 M.p.:	 151	 °C.	 IR	 (KBr,	 ν,	
cm‐1):	 1720	 (C=O),	 1625	 (C=N),	 1290	 (C‐O).	 UV/Vis	 (DMSO,	
λmax,	cm‐1):	27184,	29411,	30769.	Anal.	calcd.	for	C18H17N3O2:	C,	
70.34;	H,	5.58;	N,	13.67;	O,	10.41.	Found:	C,	69.81;	H,	5.71;	N,	
13.50;	O,	10.18%.	
	
	
	
L1	
	
	
	
L2	
	
Figure	1.	Structures	of	the	ligands.	
	
2.2.	Preparation	of	the	binuclear	metal	complexes		
	 	
The	complexes	were	prepared	easily	and	in	good	yield	from	
an	 equimolar	 ratio	 of	 the	 ligands	 (L1	 and	 L2)and	 the	 metal	
chloride.	Therefore,	after	the	addition	of	(1.0	mmol,	0.178	g)	of	
PdCl2	dissolved	in	20	mL	ethanol	and	(1.0	mmol,	0.337	g)	PtCl4	
dissolved	in	20	mL	acetone,	to	a	magnetically	stirred	1.00	mmol	
(0.548	 and	 0.534	 g)	 of	 the	 ligands	 (L1	 and	 L2,	 respectively)	
dissolved	in	30	mL	of	ethanol,	the	mixture	was	stirred	for	3	h.	
at	80	°C	till	 the	complexes	precipitated.	The	precipitated	solid	
was	 then	 filtered	 off,	 washed	 with	 diethyl	 ether,	 followed	 by	
cold	ethanol,	 and	dried	under	vacuum.	The	molar	 ratio	of	 the	
complexes	 was	 determined	 according	 to	 the	 methods	 [22].	
Proposed	structures	of	complexes	are	given	in	Figure	2.	
4‐(2,3‐Dihydroxybenzylideneamino)‐1,5‐dimethyl‐2‐phenyl‐
1H‐pyrazol‐3(2H)‐one	palladium	(II)	(Pd‐L1):	Yield:	72%.	M.p.:	
>	260	°C.	IR	(KBr,	ν,	cm‐1):	1652	(C=O),	1567	(C=N),	1262	(C‐O),	
534	 (M‐O),	 458	 (M‐N).	 UV/Vis	 (DMSO,	 λmax,	 cm‐1):	 19494,	
24630,	29411.	Anal.	calcd.	for	C36H30N6O6Pd2:	C,	50.54;	H,	3.53;	
N,	9.83;	O,	11.22;	Pd,	24.88.	Found:	C,	50.81;	H,	3.27;	N,	10.16;	
O,	10.98;	Pd,	24.36	%.	Λm	(S.	m2.mol‐1):	8.14.	μeff	=	0	μB.	
4‐(2,3‐Dihydroxybenzylideneamino)‐1,5‐dimethyl‐2‐phenyl‐
1H‐pyrazol‐3(2H)‐one	 platinum	 (IV)	 chloride	 (Pt‐L1):	 Yield:	
68%.	M.p.:	>	260	°C.	IR	(KBr,	ν,	cm‐1):	3215	(OH),	1687	(C=O),	
1576	(C=N),	1249	(C‐O),	522	(M‐O),	439	(M‐N).	UV/Vis	(DMSO,	
λmax,	cm‐1):	20106,	33297.	 	Anal.	calcd.	for	C36H30Cl2N6O6Pt2:	C,	
39.17;	H,	 2.74;	N,	 7.62;	O,	 8.70;	 Pt,	 35.35.	 Found:	 C,	 39.22;	H,	
2.43;	N,	8.56;	O,	8.48;	Pt,	35.17%.	Λm	(S.	m2.mol‐1):	126.54.	μeff	=	
5.17	μB.	
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Figure	2.	The	proposed	structures	of	the	complexes.	
	
4‐(2‐Hydroxybenzylideneamino)‐1,5‐dimethyl‐2‐phenyl‐1H‐
pyrazol‐3(2H)‐one	palladium	 (II)	chloride	 (Pd‐L2):	Yield:	69%.	
M.p.:	>	260	°C.	IR	(KBr,	ν,	cm‐1):	1687	(C=O),	1579	(C=N),	1259	
(C‐O),	541	(M‐O),	466	(M‐N).	UV/Vis	(DMSO,	λmax,	cm‐1):	20725,	
27519,	 30347.	 Anal.	 calcd.	 for	 C36H40ClN6O8Pd2:	 C,	 46.34;	 H,	
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4.32;	N,	9.01;	O,	13.72;	Pd,	 22.81.	 Found:	C,	 46.16;	H,	4.43;	N,	
9.40;	O,	13.18;	Pd,	23.27%.	Λm	(S.	m2.mol‐1):	57.41.	μeff	=	0	μB.	
4‐(2‐Hydroxybenzylideneamino)‐1,5‐dimethyl‐2‐phenyl‐1H‐
pyrazol‐3(2H)‐one	 platinum	 (IV)	 chloride	 (Pt‐L2):	 Yield:	 76%.	
M.p.:	>	260	°C.	IR	(KBr,	ν,	cm‐1):	3424	(OH),	1688	(C=O),	1573	
(C=N),	1249	(C‐O),	513	(M‐O),	434	(M‐N).	UV/Vis	(DMSO,	λmax,	
cm‐1):	16517,	35411.	Anal.	calcd.	for	C36H40Cl3N6O8Pt2:	C,	36.60;	
H,	3.45;	N,	7.12;	O,	10.84;	Pt,	33.03.	Found:	C,	36.16;	H,	3.53;	N,	
7.40;	O,	11.18;	Pt,	33.27%.	Λm	 (S.	m2.mol‐1):	161.82.	μeff	=	5.32	
μB.	
	
2.3.	Assessment	of	biological	activity	for	ligands	(L1	and	L2)	
and	their	metal	complexes		
	
The	 biological	 activity	 of	 the	 ligands	 and	 their	 metal	
complexes	 were	 assessed	 against	 four	 selected	 types	 of	
bacteria,	which	 included	Gram‐positive	bacteria	B.	subtilis	and	
S.	aureus,	 and	 Gram‐negative	 bacteria	 S.	 typhi	 and	 Salmonella	
spp.	 to	be	cultivated	and	as	control	 for	the	disc	sensitivity	test	
[23].	 This	 method	 involves	 the	 exposure	 of	 the	 zone	 of	
inhibition	toward	the	diffusion	of	microorganism	on	agar	plat.	
The	plates	were	incubated	for	24	hours	at	37	°C,	and	the	zone	
of	 inhibition	 (in	mm)	 of	 bacteria	 growth	 around	 the	disc	was	
observed.	
	
3.	Result	and	discussion	
	 	
The	 Schiff	 bases	 ligands	 are	 soluble	 in	 common	 organic	
solvents.	Nevertheless,	its	metal	complexes	are	soluble	in	DMF	
and	DMSO.	The	elemental	analysis	of	the	complexes	reveal	that	
the	compounds	have	an	ion	stoichiometry	ratio	of	metal:ligand	
(2:2),	the	analytical	data	and	other	spectral	analysis	are	in	good	
agreement	with	the	proposed	stoichiometry	of	 the	complexes.	
The	 yields,	 melting	 points,	 IR,	 and	 electronic	 absorption	
spectral	 data	 of	 all	 the	 compounds	 are	 given	 in	 the	
experimental	section.	
	
3.1.	Molar	conductance	
	
The	molar	conductance	(S.	m2/mol	at	25	°C)	measurements	
of	 the	 complexes	 in	 DMSO	 (4.14,	 46.54,	 27.41	 and	 61.82)	
correspond	to	electrolytic	nature	of	binuclear	metal	complexes.	
These	 complexes	 may	 be	 formulated	 as	 [Pd2(L1)2],	
[Pt2(L1)2(H2O)4]Cl2,	 [Pd2(L2)2]Cl,	 and	 [Pt2(L2)2(H2O)4]Cl3,	
respectively.	
	
3.2.	Infrared	spectral	study		
	
The	 most	 important	 infrared	 spectral	 bands	 of	 the	
investigated	metal	complexes	in	the	present	article	are	given	in	
the	 experimental	 section.	 The	 free	 Schiff	 base	 ligands	 are	
characterized	by	strong	band	at	1690,	1625,	and	1270	cm‐1	for	
L1,	1720,	1625,	and	1290	cm‐1	for	L2	which	may	be	ascribed	to	
the	 stretching	 vibrations	 of	 C=O,	 C=N	 (imine)	 and	 C‐O	
(phenolic)	groups,	 respectively.	The	band	at	1625	cm‐1	due	 to	
the	 stretching	mode	 of	 the	 C=N	 group	 in	 the	 spectrum	 of	 the	
free	ligands	shows	a	remarkable	blue	shift	with	splitting	in	the	
1579‐1567	cm‐1	region	in	all	the	complexes	spectra	suggesting	
that	 the	coordinating	azomethine	nitrogen	atoms	of	 the	Schiff	
bases	are	involved	in	the	complexes	formation.	
In	the	spectra	of	all	binuclear	complexes,	the	phenolic	(C‐O)	
band	is	shifted	to	lower	frequency	(8‐21	cm‐1)	for	L1	complexes	
and	 (31‐41	 cm‐1)	 for	 L2	 complexes.	 It	 is	 suggested	 that	 the	
oxygen	atom	of	the	deprotonated	phenolic	groups	are	attached	
to	the	metal	ions.	An	additional	band	at	3215	and	3424	cm‐1	for	
Pt‐L1	 and	 Pt‐L2,	 respectively,	 suggests	 that	 water	 molecules	
are	coordinated	to	metal	ion.	Additional	bands	(541‐513	cm‐1)	
of	M‐O	and	 (466‐434	cm‐1)	M‐N,	 respectively,	are	observed	 in	
the	IR	spectra	of	the	complexes.	
	
	
3.3.	Electronic	spectra		
	
The	 electronic	 spectra	 were	 recorded	 in	 DMSO.	 In	 the	
spectrum	 of	 the	 ligand,	 the	 bands	 in	 the	 26316‐29412	 cm‐1	
range	are	assigned	to	the	n	→	π*	transitions	of	the	azomethine	
group.	During	the	formation	of	the	complexes,	these	bands	are	
shifted	to	lower	wavelength,	suggesting	that	the	nitrogen	atom	
of	 the	 azomethine	 group	 is	 coordinated	 to	 the	metal	 ion.	 The	
values	in	the	30769‐34816	cm‐1	range	are	attributed	to	the	π	→	
π*	 transition	 of	 the	 aromatic	 rings.	 In	 the	 spectra	 of	 the	
complexes,	 these	 bands	 are	 shifted	 slightly	 to	 lower	
wavelength.	
The	palladium	chelates	 show	 two	 low	energy	weak	bands	
and	 one	 strong	 high‐energy	 band	 (19494,	 24630,	 29411cm‐1)	
for	Pd‐L1	and	(20725,	27519,	30347	cm‐1)	for	Pd‐L2.	These	are	
assigned	to	3A2g(F)	→	3T2g(F),	3A2g(F)	→	3T1g(F)	and	3T2g(F)	→		
3T1g(P).	 These	 three	 bands	 are	 expected	 to	 square	 planar	
geometry.	
The	 electronic	 spectra	 of	 Pt(IV)	 chelates,	 (20106,	 33297	
cm‐1)	for	Pt‐L1	and	(16517,	35411cm‐1)	for	Pt‐L2,	consist	of	one	
broad	low	energy	band,	5E1g(D)	→	5B1g(D),	and	one	strong	high	
energy	 band	 assigned	 to	 ligand‐metal	 charge	 transfer.	 The	
position	 of	 electronic	 spectral	 bands	 indicates	 that	 these	 two	
complexes	 have	 distorted	 octahedral	 geometry	 of	 D4h	
symmetry.	 The	 energy	 level	 sequence	 will	 depend	 on	 the	
amount	 of	 tetragonal	 distortion	 due	 to	 ligand	 field	 and	 Jähn‐
Tellar	distortion	effect.	
	
3.4.	Cyclic	voltammetry	
	
As	expected	for	the	Pt(IV)/Pt(II)	redox	couple,	the	platinum	
complexes	 exhibit	 a	 single	 irreversible	 reduction	 event	 in	 the	
potential	 window	 of	 +0.4	 to	 ‐1.2	 V	 vs.	 Ag/AgCl.	 The	 peak	
potentials	(Ep),	Figure	3	for	these	processes	obtained	at	a	scan	
rate	 of	 100	 mV/s	 are	 ‐0.66	 and	 ‐0.63	 for	 Pt‐L1	 and	 Pt‐L2,	
respectively.	The	redox	potential	of	platinum(IV)	complexes	 is	
therefore	believed	to	be	an	important	factor	in	their	efficacy	as	
antibiological	agents.	
	
	
	
Figure	3.	Cyclic	voltammograms	of	platinum	complexes.	
	
	
3.5.	Magnetic	susceptibility	measurements	
	
On	 the	basis	of	 the	magnetic	susceptibility	measurements,	
the	 Pd(II)	 complexes	 at	 room	 temperature	 are	 diamagnetic	
correspond	 to	 square	 planar	 geometry,	 whereas	 Pt(IV)	
complexes	 have	 paramagnetic	 character	 (5.17	 and	 5.32	 μB)	
correspond	to	high	spin	octahedral	geometry.	
	
3.6.	Antibacterial	assessment	
	
The	 ligands	 and	 their	 Pd(II)	 and	 Pt(IV)	 complexes	 were	
evaluated	 against	 different	 species	 of	 bacteria.	 The	
antibacterial	 activity	 on	 B.	 subtilis,	 S.	 aureus,	 S.	 typhi	 and	
Salmonella	 spp.	 at	 25	 °C	 was	 estimated	 by	 the	 paper	 disc	
diffusion	 technique	 [23,24].	 The	 ligands	 and	 their	 metal	
complexes	 show	 significant	 antibacterial	 activity,	 Figure	 4.	
Pt(IV)	 show	 high	 potency	 towards	 bacteria	 strains	 used.	 The	
antibacterial	 activity	 of	 Pt(IV)	 complexes	 toward	 S.	 typhi	
surpass	the	standard	antibiotic	chloramphenicol.	
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Figure	4.	 The	 effect	 of	 ligands	 and	 their	metal	 complexes	 toward	 bacteria	
(Inhibition	 zone	 diameter	 mm	 (%	 inhibition):	 6‐10	 (27‐45%);	 10‐14	 (45‐
64%);	14‐18	(64‐82%);	18‐22	(82‐100%).).	
	
4.	Conclusion	
	
Binuclear	 Pd(II)	 and	 Pt(IV)	 complexes	 of	 tridentate	 Schiff	
base	 ligands	 were	 prepared	 and	 fully	 characterized.	 The	
antibacterial	 study	 reveals	 that	 the	 complexes	 are	 quite	
efficient	towards	some	bacteria	even	more	than	the	standards	
in	many	cases.	
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